Pilot trial of CRLX101 in patients with advanced, chemotherapy-refractory gastroesophageal cancer.

about

Pilot trial of CRLX101 in patients with advanced, chemotherapy-refractory gastroesophageal cancer.

Item

http://www.wikidata.org/entity/Q47139613

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Pilot trial of CRLX101 in pati ...... ctory gastroesophageal cancer.

@en

Pilot trial of CRLX101 in pati ...... ctory gastroesophageal cancer.

@nl

type

Item

label

Pilot trial of CRLX101 in pati ...... ctory gastroesophageal cancer.

@en

Pilot trial of CRLX101 in pati ...... ctory gastroesophageal cancer.

@nl

prefLabel

Pilot trial of CRLX101 in pati ...... ctory gastroesophageal cancer.

@en

Pilot trial of CRLX101 in pati ...... ctory gastroesophageal cancer.

@nl

P1476

Pilot trial of CRLX101 in pati ...... ctory gastroesophageal cancer.

@en

P2093

Andrew J Clark

http://www.w3.org/2001/XMLSchema#string

Dean Lim

http://www.w3.org/2001/XMLSchema#string

Devin T Wiley

http://www.w3.org/2001/XMLSchema#string

Edward Garmey

http://www.w3.org/2001/XMLSchema#string

Eloise Luevanos

http://www.w3.org/2001/XMLSchema#string

James Lin

http://www.w3.org/2001/XMLSchema#string

Joseph Chao

http://www.w3.org/2001/XMLSchema#string

Mark E Davis

http://www.w3.org/2001/XMLSchema#string

Marwan Fakih

http://www.w3.org/2001/XMLSchema#string

Paul Frankel

http://www.w3.org/2001/XMLSchema#string

P2860

The interplay of immunotherapy and chemotherapy: harnessing potential synergies

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial

Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

A Phase I study of olaparib and irinotecan in patients with colorectal cancer: Canadian Cancer Trials Group IND 187.

Phase I clinical trial of weekly and daily treatment with camptothecin (NSC-100880): correlation with preclinical studies.

First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignancies

Preclinical efficacy of the camptothecin-polymer conjugate IT-101 in multiple cancer models.

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group.

Prospective, randomized, multicenter, phase III study of fluorouracil, leucovorin, and irinotecan versus epirubicin, cisplatin, and capecitabine in advanced gastric adenocarcinoma: a French intergroup (Fédération Francophone de Cancérologie Digestiv

P304

962-969

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21037/JGO.2017.08.10

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29299355

http://www.w3.org/2001/XMLSchema#string

P932

5750185

http://www.w3.org/2001/XMLSchema#string